A universal virus inactivant for decontaminating blood and biopharmaceutical products

Biologicals

Volumn 26, Issue 1, 1998, Pages 39-47

  Brown, F ^a   Meyer, R F ^a   Law, M ^a   Kramer, E ^a   Newman, J F E ^a  

^a PLUM ISLAND ANIMAL DISEASE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR; IMINE; PROTEIN; RNA POLYMERASE; VIRUS RNA; VIRUS VACCINE;

ANIMAL CELL; ARTICLE; BLOOD; CONTAMINATION; CONTROLLED STUDY; DRUG CONTAMINATION; FOOT AND MOUTH DISEASE VIRUS; FRACTIONATION; GENE AMPLIFICATION; GENE REPRESSION; NONHUMAN; NUCLEIC ACID BASE SUBSTITUTION; POLIOMYELITIS VIRUS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RETICULOCYTE; RNA TRANSLATION; TEMPERATURE; VIRUS INACTIVATION; VIRUS INFECTIVITY;

ANIMALIA; FOOT-AND-MOUTH DISEASE VIRUS; ORYCTOLAGUS CUNICULUS; POLIOVIRUS; RNA VIRUSES;

EID: 0032029173     PISSN: 10451056     EISSN: None     Source Type: Journal    
DOI: 10.1006/biol.1998.0122     Document Type: Article

References (27)

1. 1. Brown F (ed). Virological Safety Aspects of Plasma Derivatives: Dev Biol Stand 1992; Vol. 81, Karger.
2. 2. Horowitz B, Wiebe ME, Lippin A et al. Inactivation of viruses in labile blood derivatives. I. Disruption of lipid-enveloped viruses by tri (n-butyl) phosphate detergent combinations. Transfusion 1985; 25: 516-522.
3. 3. Brown F, Crick J. Application of agar gel diffusion analysis to a study of the antigenic structure of inactivated vaccines prepared from the virus of foot-and-mouth disease. J Immunol 1959; 82: 444-447.
4. 4. Bahnemann HG. Binary ethyleneimine as an inactivant for foot-and-mouth disease virus and its application for vaccine production. Arch Virol 1975; 47: 47-56.
5. 5. Twomey T, Newman J, Burrage T. et al. Structure and immunogenicity of experimental foot-and-mouth disease and poliomyelitis vaccines. Vaccine 1995; 13: 1603-1610.
6. 6. Sawyer LA, McInnis J, Albrecht P. Quantitation of D antigen content in inactivated poliovirus vaccine derived from wild-type or Sabin strains. Biologicals 1993; 21: 169-177.
7. 7. Brown F, Cartwright B. Purification of radio-active foot-and-mouth disease virus. Nature 1963; 31: 1168-1170.
8. 8. Fenwick ML. The effect of reaction with formaldehyde on the sedimentation rates of ribonucleic acids. Biochem J 1968; 107: 851-859.
9. 9. Meyer RF, Brown CC, House C et al. Rapid and sensitive detection of foot-and-mouth disease virus in tissues by enzymatic RNA amplification of the polymerase gene. J Virol Methods 1991; 34: 161-172.
10. 10. Meyer RF, Pacciarini M, Hilyard EJ et al. Genetic variation of foot-and-mouth disease virus from field outbreaks to laboratory isolation. Virus Res 1994; 32: 299-312.
11. 11. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-685.
12. 12. Meyer RF, Babcock GD, Newman JFE et al. Baculovirus expressed 2C of foot-and-mouth disease virus has the potential for differentiating convalescent from vaccinated animals. J Virol Methods 1997; 65: 33-43.
13. 13. Brown F, Wild TF. The effect of heat on the structure of foot-and-mouth disease virus and the viral ribonucleic acid. Biochim Biophys Acta 1966; 119: 301-308.
14. 14. Denoya CD, Scodeller EA, Vasquez C et al. Ribonuclease activities associated with purified foot-and-mouth disease virus. Arch Virol 1978; 57: 153-159.
15. 15. Graves JH, Arlinghaus RB. Acetylethyleneimine in the preparation of inactivated foot-and-mouth disease vaccines. Proc 71st Meeting US Livestock Sanitary Association 1967; 396-403.
16. 16. Newman JFE, Brown, F. Foot-and-mouth disease virus and poliovirus particles contain proteins of the replication complex. J Virol 1997; 71: 7657-7662.
17. 17. Bahnemann HG. Inactivation of viruses in serum with binary ethyleneimine. J Clin Microbiol 1976; 3: 209-210.
18. 18. Staple RF. Removal of acetylethyleneimine from suspensions of inactivated foot-and-mouth disease virus. Laboratory Practice 1975. 404-406.
19. 19. Rappuoli R. Toxin inactivation and antigen stabilization: two different uses of formaldehyde. Vaccine 1994; 12: 579-581.
20. 20. Ferguson M, Wood DJ, Minor PD. Antigenic structure of poliovirus in inactivated vaccines. J Gen Virol 1993; 74: 685-690.
21. 21. Anderson MC, Baer H, Frazier DJ et al. The role of specific IgE and beta-propiolactone in reactions resulting from booster doses of human diploid cell rabies vaccine. J Allerg Clin Immunol 1987; 80: 816-818.
22. 22. Swanson MC, Rosanoff E, Gurwith M et al. IgE and IgG antibodies to betapropiolactone and human serum albumin associated with urticarial reactions to rabies vaccine. J Infect Dis 1987; 155: 909-913.
23. 23. Warrington RJ, Martens CJ, Rubin M et al. Immunologic studies in subjects with a serum sickness-like illness after immunization with human diploid cell rabies vaccine. J Allerg Clin Immunol 1987; 79: 605-610.
24. 24. Bahnemann HG. Inactivation of viral antigens for vaccine preparation with particular reference to the application of binary ethyleneimine. Vaccine 1990; 8: 299-303.
25. 25. Virus Taxonomy. Classification and Nomenclature of Viruses. In: eds Murphy FA, Fauquet CM, Bishop DHL, Ghabrial SA, Jarvis AW, Martelli GP, Mayo MA, Summers MD, eds. Sixth Report of the International Committee on Taxonomy of Viruses.
26. 26. Race E, Stein CA, Wigg MD et al. A multistep procedure for the chemical inactivation of human immunodeficiency virus for use as an experimental vaccine. Vaccine 1995; 13: 1567-1575.
27. 27. Amaral-Doel CMF, Owen NE, Ferris NP et al. Detection of foot-and-mouth disease viral sequences in clinical specimens and ethyleneimine-inactivated preparations by the polymerase chain reaction. Vaccine 1993; 11: 415-421.